Luca Laurenti Selected Research

Luca Laurenti Research Topics

Disease

86	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 11/2002
24	Neoplasms (Cancer) 01/2021 - 01/2002
10	Infections 06/2021 - 08/2005
8	Lymphoma (Lymphomas) 03/2022 - 03/2007
8	Disease Progression 12/2021 - 06/2005
8	Leukemia 01/2021 - 01/2002
7	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 02/2003
6	POEMS Syndrome (Syndrome, POEMS) 12/2019 - 08/2008
6	Chromosome Aberrations (Chromosome Abnormalities) 06/2012 - 01/2002
5	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2021 - 08/2006
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 02/2003
5	Multiple Myeloma 01/2020 - 01/2002
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2019 - 01/2002
4	COVID-19 08/2022 - 01/2020
4	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2022 - 01/2017
4	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2022 - 12/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 11/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2002
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015 - 02/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 08/2011
3	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 01/2021
3	Trisomy (Trisomies) 01/2020 - 06/2019
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 01/2002
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 02/2006
3	Hodgkin Disease (Hodgkin's Disease) 06/2017 - 01/2002
3	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 01/2012
2	Bronchiolitis Obliterans Syndrome 12/2022 - 01/2019
2	Neutropenia 12/2021 - 07/2009
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2020
2	Opportunistic Infections (Opportunistic Infection) 01/2021 - 03/2002
2	Lymphocytosis 01/2021 - 09/2007
2	Acute Promyelocytic Leukemia 01/2021 - 01/2019
2	Hemolysis 12/2020 - 12/2010
2	Paraproteinemias (Monoclonal Gammopathy) 01/2020 - 04/2019
2	Cytomegalovirus Infections (Inclusion Disease) 12/2018 - 01/2010
2	Viremia 12/2018 - 03/2002
2	Sepsis (Septicemia) 02/2013 - 08/2006
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2010 - 08/2006
2	acquired Thrombotic thrombocytopenic purpura 06/2010 - 02/2008
2	Thrombotic Thrombocytopenic Purpura 06/2010 - 02/2008
2	Pathologic Complete Response 07/2007 - 03/2002
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2022
1	Body Weight (Weight, Body) 08/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2022
1	Hemorrhagic Cystitis 06/2022

Drug/Important Bio-Agent (IBA)

26	Rituximab (Mabthera)FDA Link 03/2022 - 02/2003
21	ibrutinibIBA 10/2022 - 01/2017
15	Biological ProductsIBA 01/2020 - 07/2009
11	fludarabineIBA 01/2020 - 11/2002
10	Bendamustine Hydrochloride FDA Link 03/2022 - 11/2014
9	AntigensIBA 12/2015 - 02/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2022 - 02/2007
7	Chlorambucil (Leukeran)FDA Link 12/2022 - 01/2013
7	Alemtuzumab (Campath)FDA Link 02/2014 - 10/2004
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 11/2005
5	obinutuzumabIBA 12/2022 - 01/2013
5	Immunoglobulins (Immunoglobulin)IBA 08/2022 - 06/2005
5	Monoclonal AntibodiesIBA 01/2016 - 02/2003
4	Lenalidomide (CC 5013)FDA Link 04/2018 - 06/2012
4	ofatumumab FDA Link 01/2016 - 12/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 02/2014
3	venetoclaxIBA 01/2022 - 01/2016
3	idelalisibIBA 08/2021 - 01/2021
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 07/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2008
3	Phosphotransferases (Kinase)IBA 01/2020 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 04/2019 - 08/2008
3	Pharmaceutical PreparationsIBA 01/2018 - 03/2002
3	Hemoglobins (Hemoglobin)IBA 11/2017 - 09/2007
3	AntibodiesIBA 03/2015 - 02/2008
2	zanubrutinibIBA 01/2022 - 10/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 05/2018
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2020
2	SteroidsIBA 11/2021 - 08/2006
2	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 01/2019
2	Immunoglobulin M (IgM)IBA 01/2020 - 04/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 11/2005
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 12/2014
2	Sirtuin 1IBA 08/2015 - 07/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2012 - 01/2012
2	Syk KinaseIBA 05/2011 - 07/2009
2	Immunoglobulin Variable RegionIBA 01/2011 - 11/2008
2	Methylprednisolone FDA LinkGeneric 06/2010 - 02/2006
2	EpitopesIBA 11/2008 - 09/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2007 - 02/2006
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 08/2022
1	Antiviral Agents (Antivirals)IBA 01/2022

Therapy/Procedure

35	Therapeutics 08/2022 - 10/2004
11	Stem Cell Transplantation 12/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2002
9	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2018 - 02/2003
7	Transplantation 01/2019 - 01/2002
5	Hematopoietic Stem Cell Transplantation 06/2022 - 01/2002
5	Radiotherapy 01/2018 - 01/2002
4	Time-to-Treatment 06/2019 - 07/2007
3	Homologous Transplantation 01/2021 - 03/2002
3	Immunotherapy 12/2020 - 01/2017
2	Hematopoietic Stem Cell Mobilization 12/2019 - 04/2018
1	Self Administration (Administration, Self) 08/2022